Equities

Vivos Inc

RDGL:QBB

Vivos Inc

Actions
Basic MaterialsChemicals
  • Price (USD)0.1997
  • Today's Change-0.015 / -7.12%
  • Shares traded6.51m
  • 1 Year change+182.46%
  • Beta0.9836
Data delayed at least 15 minutes, as of May 03 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Vivos Inc. is a radiation oncology medical device company. The Company is engaged in the development of its yttrium-90 (Y-90) based brachytherapy device, RadioGel, for the treatment of non-resectable tumors. RadioGel is a device for human therapy for non-resectable cancers in humans. It is a hydrogel liquid containing tiny Yttrium-90 phosphate microparticles that may be administered directly into a tumor. The Company’s IsoPet division is focused on bringing RadioGel yttrium-90 precision radionuclide therapy to veterinary oncologists to treat dogs, cats and horses suffering from cancerous tumors. The IsoPet solutions division used university veterinary hospitals to demonstrate the safety and therapeutic effectiveness for different animal cancers. The Company is also engaged in developing a micro-injection system for small tumor therapy for treating cancerous thyroid lymph nodes.

  • Revenue in USD (TTM)19.50k
  • Net income in USD-2.89m
  • Incorporated2000
  • Employees10.00
  • Location
    Vivos Inc719 Jadwin AveRICHLAND 99352-4217United StatesUSA
  • Phone+1 (509) 736-4000
  • Fax+1 (509) 736-4007
  • Websitehttps://www.radiogel.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Hyperfine Inc11.03m-44.24m57.61m131.00--0.6815--5.22-0.6205-0.62050.15471.170.09671.124.1784,213.74-38.76---42.00--43.12---401.00--9.39--0.00--61.90--39.54------
Autonomix Medical Inc0.00-10.68m57.70m3.00---------0.5055-0.50550.00-0.2649------0.00----------------------------84.50------
Heartbeam Inc0.00-14.64m58.19m15.00--3.65-----0.9404-0.94040.000.60530.00----0.00-138.30---159.89--------------0.00-------12.94------
Medinotec Inc3.05m-566.90k58.67m29.00--28.27--19.24-0.0483-0.04830.25980.17690.67122.0616.96105,130.70-12.48---13.23--53.56---18.59--8.571.440.4323---3.91---184.47------
Beyond Air Inc689.00k-66.70m59.67m98.00--2.22--86.60-2.13-2.130.02190.58670.0111.441.247,030.61-112.64-70.88-148.49-88.69-115.24---10,288.68-1,530.313.26--0.382-------29.27------
Sensus Healthcare Inc24.41m485.00k59.84m35.00125.211.2278.742.450.02920.02921.502.980.4421.131.75697,314.300.878310.290.984412.1457.6162.851.9915.298.23--0.00---45.20-1.58-98.00---23.16--
Pro-Dex Inc48.24m5.00m62.40m146.0013.122.0310.321.291.391.3913.448.980.97462.303.68330,438.3010.1115.4312.9418.8728.2533.1510.3714.922.16--0.27530.009.6215.4654.7232.380.8422--
IR-MED Inc0.00-4.91m62.94m6.00--172.43-----0.0714-0.07140.000.00520.00----0.00-228.70---310.89--------------0.3061-------3.70------
DIH Holding US Inc60.30m-1.77m63.25m--------1.05-0.0435-0.04351.49-0.8079----------------60.18---2.93--0.26561.50----12.15--80.41------
Asensus Surgical Inc8.58m-78.43m65.55m207.00--1.91--7.64-0.3162-0.31620.03440.12610.0981.702.9841,434.78-89.57-71.10-103.14-79.04-53.38-71.39-914.46-1,207.712.31--0.00--21.02-18.67-3.80---6.14--
Alpha Pro Tech, Ltd.61.23m4.19m71.18m124.0017.191.1313.921.160.35430.35435.165.390.91691.7211.25493,814.506.2715.216.5216.0637.2840.236.8412.9312.83--0.000.00-1.215.6027.642.935.50--
Monogram Orthopaedics Inc365.00k-13.75m73.53m28.00------201.46-0.4621-0.46210.0123--0.0241----13,035.71-90.82-119.26-149.39-257.400.00---3,765.81-5,045.60----0.00-------0.3964---15.97--
Vivos Inc19.50k-2.89m77.46m10.00--56.85--3,972.43-0.0079-0.00790.000050.00350.0116--2.17---172.67-202.25-191.32-552.77-30.9710.79-14,844.92-11,969.07----0.00---46.58---17.19------
Vuzix Corp12.13m-50.15m84.79m94.00--1.05--6.99-0.7893-0.78930.19121.250.1111.463.10129,033.50-45.91-41.61-50.66-44.80-21.72-6.13-413.46-317.286.23--0.00--2.488.42-23.02--39.42--
Envoy Medical Inc316.00k-29.91m85.26m34.00------269.81-2.60-2.600.0207-0.0899------9,294.12---------149.68---9,464.56--0.8169-266.25----33.33---87.83------
Data as of May 03 2024. Currency figures normalised to Vivos Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.